Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

1.910 -0.070 (-3.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,471,253
Open 1.970
Bid (Size) 1.910 (210)
Ask (Size) 1.940 (17)
Prev. Close 1.980
Today's Range 1.860 - 2.025
52wk Range 0.3450 - 2.105
Shares Outstanding 257,328,085
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+190.45%
+190.45%
1 Month
+32.64%
+32.64%
3 Month
+101.24%
+101.24%
6 Month
+391.26%
+391.26%
1 Year
+190.23%
+190.23%

More News

Read More
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – OCGN
From The Rosen Law Firm PA
Via GlobeNewswire
4 Analysts Assess Ocugen: What You Need To Know
Via Benzinga
OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024
Via InvestorPlace
Nayax Posts Weak Q1 Results, Joins GameStop, Iris Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
From Faruqi & Faruqi LLP
Via GlobeNewswire
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy
From Ocugen
Via GlobeNewswire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
Ocugen Provides Business Update with First Quarter 2024 Financial Results
From Ocugen
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
OCUGEN (NASDAQ: OCGN) INVESTOR ALERT: June 10, 2024 Lead Plaintiff Deadline - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
OCUGEN (NASDAQ: OCGN) INVESTOR ALERT: June 10, 2024 Lead Plaintiff Deadline - Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Topics Regulatory Compliance
Exposures Legal Regulatory
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
From Ocugen
Via GlobeNewswire
OCUGEN (NASDAQ: OCGN) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Ocugen Investors of a Class Action Lawsuit and June 10, 2024 Lead Plaintiff Deadline
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
OCUGEN (NASDAQ: OCGN) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Ocugen Investors of a Class Action Lawsuit and June 10, 2024 Lead Plaintiff Deadline
Via TheNewswire.com
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
Ocugen to Present at May 2024 Investor Conferences
From Ocugen
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
ROSEN, A RANKED AND LEADING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A RANKED AND LEADING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
From Faruqi & Faruqi LLP
Via GlobeNewswire
Millionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.